Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Transfusion ; 57(6): 1376-1384, 2017 06.
Article in English | MEDLINE | ID: mdl-28419488

ABSTRACT

BACKGROUND: Hepatitis C virus (HCV) is the major posttransfusion infection in multitransfused individuals in India with thalassemia major. To our knowledge, this study is the first conducted to correlate and comprehend the effects of the host interleukin (IL)28B gene polymorphism at loci rs12979860 and rs8099917 in spontaneous or interferon (IFN)-induced treatment response in the HCV-seroreactive individuals with thalassemia major. STUDY DESIGN AND METHODS: A total of 557 HCV-seroreactive individuals with thalassemia were processed for HCV viral genotyping and host IL28B single-nucleotide polymorphism analysis at loci rs12979860 and rs8099917. RESULTS: Of 557 individuals, 70.92% were found to be HCV RNA positive with Genotype 3 (95.18%) as predominant strain. A favorable CC allele at locus rs2979860 and TT allele at rs8099917 were 75.31 and 77.16%, respectively, which was strongly associated with spontaneous clearance of infection (p < 0.05). Of 85 IFN-treated cases, 56 achieved sustained virologic response (SVR) whereas 27 were relapsed cases. Among these patients who achieved SVR, a favorable CC/TT allele at rs12979860/rs8099917 was found to be predominant with 76.79 and 66.07%, respectively, whereas in the case of relapsed patients, unfavorable CT (55.56%) and TG (59.26%) alleles were found to be predominant. Additionally, low serum ferritin level was significantly associated with SVR. CONCLUSION: CC at rs12979860 and TT at rs8099917 was strongly associated with spontaneous clearance and SVR in the population with thalassemia. Low age group and low serum ferritin level are important cofactors. This allelic pattern will aid clinicians in making an informed decision about prognosis and therapeutic management.


Subject(s)
Blood Transfusion , Hepatitis C, Chronic/pathology , Hepatitis C, Chronic/virology , Interleukins/genetics , Polymorphism, Single Nucleotide/genetics , Thalassemia/genetics , Thalassemia/therapy , Adolescent , Alleles , Child , Child, Preschool , Female , Ferritins/blood , Genotype , Hepacivirus/pathogenicity , Hepatitis C, Chronic/blood , Hepatitis C, Chronic/genetics , Humans , Interferons , Male , Thalassemia/blood , Thalassemia/virology , Treatment Outcome
2.
Infect Genet Evol ; 48: 156-163, 2017 03.
Article in English | MEDLINE | ID: mdl-27923769

ABSTRACT

Recombination in RNA virus is a rare event in the survival and evolution to evade host immune system. This is increasing within high risk group population (HRG) due to super infection that occurs by continuous sharing of common drug equipment by HCV infected or HIV-HCV co-infected recurrent drug users. Recombination causes impediment to vaccine development and therapeutic intervention as standard HCV treatment is still genotype specific. Blood samples of 194 people who inject drugs (PWID) were collected from an Opioid Substitution Therapy Centre in Kolkata, India. HCV sero-reactivity was checked by ELISA. Detection of HCV RNA by nested RT-PCR and genotyping by DNA sequencing were done. Phylogenetic analysis, Simplot, Bootscan plot, Recombination Detection Program were used for recombinant strain identification. Out of 80 HCV sero-reactive samples, 77 were RNA positive (96.25%). Out of 74 HIV mono-infected individuals, 12 HCV sero-nonreactive samples were HCV RNA positive. Out of total 89 RNA positive samples, 64 paired partial core and NS5B region (71.9%) were sequenced by Sanger's method. Two major genotypes (1 and 3), four subtypes and an inter-genotype recombinant strain (3a/1a) with a novel breakpoint in the NS4B coding region were found.


Subject(s)
Coinfection/virology , HIV Infections/virology , Hepacivirus/genetics , Hepatitis C/virology , Substance Abuse, Intravenous/virology , Adult , Drug Users , Evolution, Molecular , HIV Infections/epidemiology , Hepatitis C/epidemiology , Humans , India/epidemiology , Male , Middle Aged , Phylogeny , Prevalence , RNA, Viral/genetics , Recombination, Genetic , Sequence Analysis, DNA , Substance Abuse, Intravenous/epidemiology , Viral Nonstructural Proteins/genetics
3.
J Med Virol ; 88(10): 1697-702, 2016 10.
Article in English | MEDLINE | ID: mdl-26991505

ABSTRACT

Dengue virus infection is a major cause of morbidity within the endemic tropical and subtropical regions of the world. Dengue virus has four distinct serotypes with specific clinical manifestations. In this study, we observed the changing pattern of dengue serotypes, age-wise dengue infection and useful sero-detection methods needed in a dengue endemic region. We identified dengue serotypes during a period of 5 years among patients with dengue symptoms visiting one of the largest tertiary care infectious disease hospitals of eastern India in Kolkata. A total of 433 dengue RNA positive samples were isolated from 712 acute dengue suspected cases. Age wise distribution highlighted the susceptible age group being >21 years (24.02%) followed by 11-15 years (21.71%) and 5-10 years (21.02%) of the total infected population. Higher numbers of infected cases were found within females as they are involved in more indoor works. The period of study experienced two dengue outbreaks one in 2008 and another in 2012. For early dengue detection, NS1 was found to be more confirmatory than IgM ELISA regarding sensitivity and specificity. DENV-1, 2, and 4 serotypes were the common circulating strains from 2008 until 2010, after which DENV-3 serotype infections rise and led to a massive dengue outbreak in Kolkata with increased numbers of DHF and DSS cases in 2012. The finding within our study emphasizes the public health importance of such prospective surveillance programs with respect to the changing dengue viral etiology and serotypes. J. Med. Virol. 88:1697-1702, 2016. © 2016 Wiley Periodicals, Inc.


Subject(s)
Dengue Virus/genetics , Dengue Virus/immunology , Dengue/epidemiology , Dengue/virology , Disease Outbreaks , Severe Dengue/epidemiology , Severe Dengue/virology , Adolescent , Adult , Age Factors , Child , Child, Preschool , Dengue/diagnosis , Dengue/immunology , Dengue Virus/classification , Enzyme-Linked Immunosorbent Assay , Epidemiological Monitoring , Female , Humans , India/epidemiology , Male , Prospective Studies , RNA, Viral/blood , Serogroup , Serotyping , Severe Dengue/diagnosis , Severe Dengue/immunology , Sex Factors , Viral Nonstructural Proteins/immunology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...